Purchase Order 75N91019P00330

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on August 31, 2020, for biological and reagent material with a firm fixed price. Place of performance is Marshallton, Delaware, with an ultimate completion date of September 30, 2020. The order was not set-aside and reflects full and open competition.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $13,097.50 on May 21, 2021, for biologicals and reagents with an ultimate completion date of June 4, 2021. No set-aside was used. Performance occurs in Marshallton, Delaware. The order is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for a reagent kit valued at $16,259.00 on August 26, 2019, with completion by September 18, 2019. Place of performance is Marshallton, Delaware. No set-aside was used. The order was issued on a firm fixed price basis for commercial laboratory consumables, consistent with Agilent's role as a supplier of analytical instrumentation and related supplies to federal research agencies.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $24,998.51 in scientific laboratory equipment on March 11, 2021, with an ultimate completion date of May 31, 2021. Performance takes place in Marshallton, Delaware. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $17,948.50 on September 19, 2019, for drugs and biologicals, with ultimate completion on October 19, 2019. Place of performance is Bethesda, Maryland. The order uses firm fixed-price pricing with no set-aside category.</p>

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $12,904.00, with an award date of August 22, 2017 and ultimate completion on September 22, 2017. Performance takes place in Marshallton, Delaware. The order is a firm fixed price procurement for analytical laboratory equipment or consumables, consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $11,998.80 on October 29, 2019, for a maintenance agreement with an ultimate completion date of October 31, 2020. Place of performance is Marshtonlon, Delaware. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on February 7, 2014, valued at $4,075.65, with completion by February 28, 2015. Performance occurs at Marshallton, Delaware. The order carries no set-aside designation and uses firm fixed pricing.</p>

<p>The National Cancer Institute issued a $40,929.49 delivery order to Agilent Technologies Inc. on May 18, 2020, for scientific equipment.</p> <p>Place of performance is Marshtonlon, DE. The order has a firm fixed price and an ultimate completion date of June 30, 2020. No set-aside was used.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,884.50 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for BIOLOGICAL KITS. The place of performance will be in Marshallton, Delaware and the period of performance is one month from June 29, 2023 through July 31, 2023. As the prime contractor, Agilent Technologies Inc. will deliver the requested biological kits to support the...